GSK Finance Exec Blocked From Leaving China, Co. Says

Law360, New York (July 17, 2013, 5:31 PM ET) -- GlaxoSmithKline PLC on Wednesday said Beijing is barring the head of finance for its Chinese unit from leaving the country, amid accusations that the British drugmaker bribed doctors and hospitals to boost drug sales.

GSK said it has been aware of the travel restrictions imposed on Steve Nechelput, director of finance for GSK China, since the end of June. Though Nechelput, a British citizen, is being prevented from leaving the country, a GSK spokeswoman stressed that he is not under arrest or otherwise detained and that...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required